| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,511 |
24,857 |
$1.51M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,384 |
5,055 |
$387K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,650 |
4,216 |
$369K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,951 |
4,418 |
$348K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,855 |
2,721 |
$198K |
| 92552 |
|
5,663 |
5,323 |
$137K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,014 |
5,595 |
$58K |
| 90686 |
|
5,251 |
4,929 |
$57K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,064 |
3,726 |
$50K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,951 |
1,761 |
$45K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
567 |
539 |
$43K |
| 90670 |
|
2,125 |
2,011 |
$43K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
862 |
799 |
$32K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,202 |
1,065 |
$32K |
| 90698 |
|
1,977 |
1,868 |
$30K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,609 |
1,523 |
$16K |
| 81003 |
|
7,511 |
7,066 |
$15K |
| 92551 |
|
1,634 |
1,552 |
$15K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,242 |
1,177 |
$10K |
| 99174 |
|
2,163 |
2,018 |
$10K |
| 99070 |
|
2,577 |
2,347 |
$7K |
| 85013 |
|
2,991 |
2,858 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
260 |
198 |
$7K |
| 99173 |
|
3,145 |
2,996 |
$7K |
| 99188 |
|
359 |
341 |
$7K |
| 90680 |
|
442 |
421 |
$6K |
| S8301 |
Infection control supplies, not otherwise specified |
3,992 |
3,468 |
$6K |
| 99072 |
|
7,216 |
6,428 |
$6K |
| 90656 |
|
379 |
367 |
$5K |
| 96127 |
|
964 |
907 |
$5K |
| 90672 |
|
356 |
353 |
$4K |
| 90685 |
|
298 |
287 |
$3K |
| 90716 |
|
169 |
154 |
$3K |
| 90633 |
|
228 |
220 |
$3K |
| 90707 |
|
181 |
166 |
$2K |
| 90744 |
|
185 |
169 |
$2K |
| 90651 |
|
71 |
66 |
$2K |
| 99000 |
|
757 |
710 |
$2K |
| 90671 |
|
45 |
37 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
83 |
81 |
$1K |
| 90677 |
|
15 |
15 |
$1K |
| 90660 |
|
75 |
75 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
12 |
$925.24 |
| 90619 |
|
31 |
29 |
$758.45 |
| 36416 |
|
3,249 |
3,019 |
$756.59 |
| 99051 |
|
981 |
919 |
$546.66 |
| 99441 |
|
13 |
13 |
$480.00 |
| 90700 |
|
24 |
24 |
$252.24 |
| 90713 |
|
24 |
24 |
$252.24 |
| 90734 |
|
13 |
13 |
$246.74 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
69 |
66 |
$169.97 |
| 90473 |
|
33 |
33 |
$75.30 |
| 85018 |
|
42 |
36 |
$57.73 |